Add BrightSurf on Google Email

Listen to your heart: AI tool detects cardiac diseases that doctors often miss

Researchers developed an AI tool that can detect valvular heart disease with 93% sensitivity and 98% specificity. The tool analyzes audio data from a short burst of sound vibrations using a contact microphone and neural networks, allowing for quick identification of five different valvular diseases.

SourceStevens Institute of Technology·JournalIEEE Transactions on Biomedical Engineering·TypeRandomized controlled/clinical trial·DateOct 9, 2023

Obesity, high blood pressure, and lipid imbalance trigger a progressive loss of energy generation capacity in the heart

A study published in Diabetes Care found that obesity, hypertension, and dyslipidemia alter cardiac energy production by interfering with metabolic substrate uptake. The research reveals early changes in apparently healthy middle-aged individuals, highlighting the importance of identifying mechanisms involved in heart disease onset.

SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalDiabetes Care·TypeRandomized controlled/clinical trial·DateOct 3, 2023

Job strain combined with high efforts and low reward doubled men’s heart disease risk

A new study published in Circulation: Cardiovascular Quality and Outcomes journal reveals that men who experience job strain combined with high efforts and low reward have doubled the risk of heart disease. The research highlights the pressing need to proactively address stressful working conditions to create healthier work environments.

SourceAmerican Heart Association·JournalCirculation Cardiovascular Quality and Outcomes·DateSep 19, 2023

Knowing the genetic cause of high cholesterol predicts disease risk better than cholesterol levels alone, study finds

A Geisinger-led study found that knowing the genetic cause of high cholesterol increases heart disease risk more than having high cholesterol levels alone. The study used UK Biobank data and observed distinct differences in heart disease rates among participants with different genetic causes.

SourceGeisinger Health System·JournalArteriosclerosis Thrombosis and Vascular Biology·DateSep 18, 2023

UCLA research suggests that heart transplantation is safer for adults with single-ventricle CHD than previously thought

Researchers analyzed data from 2005-2020 and found that 10-year conditional survival was similar between biventricular and most single-ventricle CHD patients. Biventricular CHD patients also showed better 10-year survival compared to non-CHD heart transplant recipients.

SourceUniversity of California - Los Angeles Health Sciences·JournalJournal of the American College of Cardiology·TypeData/statistical analysis·DateSep 11, 2023

Software developed at UC Davis analyzes calcium ‘sparks’ that can contribute to arrhythmia

Researchers at UC Davis have developed SparkMaster2, an open-source software that analyzes normal and abnormal calcium activity in human cells. The tool can identify calcium sparks associated with irregular heartbeats, or arrhythmia, enabling better understanding of the underlying biology.

SourceUniversity of California - Davis Health·JournalCirculation Research·TypeData/statistical analysis·DateSep 1, 2023

Recent study at UC Irvine found that semaglutide medication may benefit 93 million U.S. adults

A recent study at UC Irvine found that semaglutide medication can lead to significant weight loss and reduce cardiovascular risk in 93 million U.S. adults. The medication may prevent up to 1.5 million heart attacks and strokes over 10 years, resulting in 43 million fewer obese people.

SourceUniversity of California - Irvine·JournalCardiovascular Drugs and Therapy·TypeData/statistical analysis·DateAug 15, 2023

Fiber-infused ink enables 3D-printed heart muscle to beat

Researchers at Harvard developed a fiber-infused ink that allows 3D-printed heart muscle cells to align and contract like human heart cells, enabling the creation of functional heart ventricles. The innovation can be used to build life-like heart tissues with thicker muscle walls, paving the way for regenerative therapeutics.

Octapharma's prothrombin complex concentrate, Balfaxar®, receives FDA approval for warfarin reversal in urgent surgery & invasive procedures

Octapharma's Balfaxar, a prothrombin complex concentrate, has received FDA approval for the urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist therapy. The product demonstrated effective hemostasis in 94.6% of patients and was non-inferior to comparator Kcentra.

SourceYankee Public Relations·TypeObservational study·DateJul 26, 2023

Cause of sleep disturbance in cardiac disease identified: Ganglia play previously unrecognized role

A study published in Science reveals that ganglia in the neck region are responsible for disrupting melatonin production and causing sleep disturbances in people with heart conditions. Researchers found that macrophages accumulate in the ganglion, leading to inflammation and scarring, which can be treated with drugs.

SourceTechnical University of Munich (TUM)·JournalScience·TypeExperimental study·DateJul 20, 2023

AI finds a way to people’s hearts (literally!)

Researchers developed an AI model that accurately classifies six types of valvular heart disease using chest radiographs, with high accuracy rates. The model's potential applications include supplementing echocardiography in areas where specialists are scarce and improving emergency care.

SourceOsaka Metropolitan University·JournalThe Lancet Digital Health·TypeExperimental study·DateJul 6, 2023

“Anchoring bias” can delay testing and diagnosis by physicians for deadly conditions like blood clots in the lung

Researchers found that when a patient's congestive heart failure is mentioned during the initial check-in process, emergency room physicians are less likely to test for pulmonary embolism, potentially leading to delays in diagnosis. This anchoring bias can delay crucial testing and diagnosis of deadly medical conditions.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA Internal Medicine·TypeData/statistical analysis·DateJun 26, 2023